108 related articles for article (PubMed ID: 23549218)
1. Rifaximin: a nonsystemic antibiotic for hepatic encephalopathy.
Welliver M
Gastroenterol Nurs; 2013; 36(2):140-2. PubMed ID: 23549218
[No Abstract] [Full Text] [Related]
2. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections.
Cottreau J; Baker SF; DuPont HL; Garey KW
Expert Rev Anti Infect Ther; 2010 Jul; 8(7):747-60. PubMed ID: 20586560
[TBL] [Abstract][Full Text] [Related]
3. Rifaximin (Xifaxan 550) for hepatic encephalopathy.
Med Lett Drugs Ther; 2010 Nov; 52(1350):87. PubMed ID: 21045761
[No Abstract] [Full Text] [Related]
4. Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety.
Williams R; Bass N
Rev Gastroenterol Disord; 2005; 5 Suppl 1():S10-8. PubMed ID: 15976747
[TBL] [Abstract][Full Text] [Related]
5. Ammonia abolishers: antibiotics for hepatic encephalopathy.
Felicilda-Reynaldo RF
Medsurg Nurs; 2012; 21(3):173-5; quiz 176. PubMed ID: 22866441
[No Abstract] [Full Text] [Related]
6. Management of hepatic encephalopathy: role of rifaximin.
Zeneroli ML; Avallone R; Corsi L; Venturini I; Baraldi C; Baraldi M
Chemotherapy; 2005; 51 Suppl 1():90-5. PubMed ID: 15855752
[TBL] [Abstract][Full Text] [Related]
7. Biologic properties and clinical uses of rifaximin.
DuPont HL
Expert Opin Pharmacother; 2011 Feb; 12(2):293-302. PubMed ID: 21226639
[TBL] [Abstract][Full Text] [Related]
8. Rifaximin for the treatment of hepatic encephalopathy.
Mullen K; Prakash R
Expert Rev Gastroenterol Hepatol; 2010 Dec; 4(6):665-77. PubMed ID: 21108586
[TBL] [Abstract][Full Text] [Related]
9. Review article: the current pharmacological therapies for hepatic encephalopathy.
Bass NM
Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():23-31. PubMed ID: 17295849
[TBL] [Abstract][Full Text] [Related]
10. [Rifaximin for hepatic encephalopathy in children. Case report].
Malla I; Torres Cerino V; Villa A; Cheang Y; Giacove G; Pedreira A; Silva M
Arch Argent Pediatr; 2011 Dec; 109(6):e113-5. PubMed ID: 22231877
[TBL] [Abstract][Full Text] [Related]
11. Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial.
Miglio F; Valpiani D; Rossellini SR; Ferrieri A
Curr Med Res Opin; 1997; 13(10):593-601. PubMed ID: 9327194
[TBL] [Abstract][Full Text] [Related]
12. Rifaximin: an alternative for the treatment of hepatic encephalopathy.
Rigali VT
Conn Med; 2006 Sep; 70(8):499-501. PubMed ID: 17089807
[No Abstract] [Full Text] [Related]
13. Rifaximin for treatment of hepatic encephalopathy.
Maclayton DO; Eaton-Maxwell A
Ann Pharmacother; 2009 Jan; 43(1):77-84. PubMed ID: 19092143
[TBL] [Abstract][Full Text] [Related]
14. [Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy].
MMW Fortschr Med; 2014 Feb; 156(3):64-5. PubMed ID: 24938070
[No Abstract] [Full Text] [Related]
15. [Clinical and pharmacological aspects of rifaximin, local antibiotic therapy in intestinal disorders].
Gasztonyi B; Hunyady B
Orv Hetil; 2004 Oct; 145(43):2177-81. PubMed ID: 15575494
[TBL] [Abstract][Full Text] [Related]
16. Rifaximin: new therapeutic indication and future directions.
Rivkin A; Gim S
Clin Ther; 2011 Jul; 33(7):812-27. PubMed ID: 21741091
[TBL] [Abstract][Full Text] [Related]
17. Durability of rifaximin response in hepatic encephalopathy.
Neff GW; Jones M; Broda T; Jonas M; Ravi R; Novick D; Kaiser TE; Kemmer N
J Clin Gastroenterol; 2012 Feb; 46(2):168-71. PubMed ID: 22011586
[TBL] [Abstract][Full Text] [Related]
18. Rifaximin for the treatment of hepatic encephalopathy.
Mantry PS; Munsaf S
Transplant Proc; 2010 Dec; 42(10):4543-7. PubMed ID: 21168733
[TBL] [Abstract][Full Text] [Related]
19. Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections.
Gerard L; Garey KW; DuPont HL
Expert Rev Anti Infect Ther; 2005 Apr; 3(2):201-11. PubMed ID: 15918778
[TBL] [Abstract][Full Text] [Related]
20. Rifaximin for the treatment of hepatic encephalopathy.
Lawrence KR; Klee JA
Pharmacotherapy; 2008 Aug; 28(8):1019-32. PubMed ID: 18657018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]